OMERS ADMINISTRATION Corp lowered its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 14.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 70,210 shares of the conglomerate’s stock after selling 11,957 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Danaher were worth $13,312,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new position in shares of Danaher in the 4th quarter valued at $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the 4th quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd lifted its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at about $25,000. Finally, Main Street Group LTD bought a new position in Danaher in the first quarter valued at about $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on DHR shares. Barclays dropped their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. TD Cowen decreased their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a report on Wednesday. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.
Danaher News Summary
Here are the key news stories impacting Danaher this week:
- Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
- Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
- Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
- Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
- Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction
Danaher Stock Performance
Shares of DHR stock opened at $191.87 on Monday. The firm has a market capitalization of $134.88 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 2.38 and a beta of 0.79. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average price is $185.64 and its 200-day moving average price is $196.76. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 earnings per share. Equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 28.42%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
